Paris, October 26, 2023
- Net sales reached €6,906m in Q3 2023, up +6.2% on a like-for-like (LFL) basis, supported by a sequential improvement in volume/mix (-0.3%) led by EDP
- Good momentum across the portfolio, with further progress on Renew Danone agenda:
- EDP transformation in Europe starts delivering results, with volume/mix sequentially improving, giving confidence for next quarters
- Continued solid dynamics in China led by Medical Nutrition and Infant Milk Formula; robust growth during peak season for Mizone confirming turnaround
- Resilient performance in North America supported by Coffee Creations and Yogurts
- Strong broad-based growth in AMEA and Latin America
- 2023 guidance raised: like-for-like sales growth now expected between +6% and +7% (versus between +4% and +6% previously); moderate improvement in recurring operating margin confirmed